News & Updates
Filter by Specialty:
Apremilast safe, effective in moderate-to-severe genital psoriasis
13 Apr 2023
byStephen Padilla
Treatment with apremilast demonstrates consistent efficacy in genital psoriasis and overall psoriasis symptoms at 16 weeks irrespective of body surface area (BSA) at baseline, suggest the results of the phase III DISCREET trial presented at the recent AAD 2023.
Apremilast safe, effective in moderate-to-severe genital psoriasis
13 Apr 2023Mirabegron may improve sexual function in adults with OAB
13 Apr 2023
byAudrey Abella
Mirabegron, a ß3 adrenoceptor agonist, delivers benefit for both men and women with overactive bladder (OAB) who are experiencing sexual dysfunction, a systematic review and meta-analysis reports.
Mirabegron may improve sexual function in adults with OAB
13 Apr 2023Lebrikizumab helps clear skin of teens with moderate-to-severe atopic dermatitis
12 Apr 2023
byStephen Padilla
Treatment with lebrikizumab with or without topical corticosteroids (TCS) results in clinical improvement among adolescents with moderate-to-severe atopic dermatitis (AD), according to a study presented at the recent AAD 2023.